Home > Quotes > MNTA > Company News

Momenta Pharmaceuticals, Inc. News Headlines

MNTA 
$13.31
*  
0.05
  negative  
0.38%
Get MNTA Alerts
*Delayed - data as of May 23, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MNTA Pre-Market
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry
5/22/2013 12:56:00 PM - Seeking Alpha

Momenta Pharma To Present At UBS Global Conference ; Webcast At 11:00 AM
5/22/2013 10:00:00 AM - RTT News

Momenta Pharma To Present At Bank Of America Conference; Webcast At 7:20 PM ET
5/15/2013 3:00:00 PM - RTT News

5 Names Seeing Bullish Options Flow
5/2/2013 12:00:00 PM - TheStreet

Loss Widens at Momenta - Analyst Blog
5/2/2013 9:57:19 AM - Zacks.com

Momenta Pharma Q1 Loss Widens
4/30/2013 12:36:00 PM - RTT News

Stocks With Upcoming Legal Catalysts
3/27/2013 8:40:00 AM - Seeking Alpha

Momenta To Present At Barclays Global Healthcare Conference; Webcast At 8:00 AM
3/14/2013 7:01:00 AM - RTT News

Momenta To Present At Cowen HealthCare Conference; Webcast At 1:30 PM ET
3/4/2013 12:30:00 PM - RTT News

Momenta To Present At RBC Capital Markets Conference; Webcast At 3:00 PM ET
2/27/2013 2:02:00 PM - RTT News

Loss at MNTA Narrower than Expected - Analyst Blog
2/19/2013 5:29:01 PM - Zacks.com

4 Low-Debt Healthcare Stocks Raking In Profits
9/14/2012 11:55:00 AM - Seeking Alpha

Another Copaxone Win for Teva - Analyst Blog
7/12/2012 4:46:59 PM - Zacks.com

Mylan's Guidance Remains Unchanged - Analyst Blog
6/27/2012 1:11:12 PM - Zacks.com

Company News for June 26, 2012 - Corporate Summary
6/26/2012 10:06:01 AM - Zacks.com

Favorable Copaxone Ruling for Teva - Analyst Blog
6/25/2012 4:00:01 PM - Zacks.com

Generic Competition: The $100 Billion Biologics Arena
3/6/2012 1:13:00 PM - Seeking Alpha

VIX - Options Volatility Sonar: Thursday Recap
3/1/2012 5:00:00 PM - Seeking Alpha

4 Compelling Alternatives To Vertex Pharma
2/23/2012 8:21:00 AM - Seeking Alpha

Biotech Stocks: Analysts Identify 5 Potential Takeover Targets
2/20/2012 4:29:00 AM - Seeking Alpha

5 Overlooked Healthcare Stocks To Consider Now
2/18/2012 6:22:00 PM - Seeking Alpha

5 Biotech Stocks Undervalued By EPS Trends
2/13/2012 3:21:00 AM - Seeking Alpha

Magic Formula?
2/7/2012 8:41:00 AM - Seeking Alpha

Biotech Buyout Portfolio: Momenta Pharmaceuticals
2/6/2012 7:49:00 AM - Seeking Alpha

Verastem: Killing Cancer At The Root
2/2/2012 6:55:00 AM - Seeking Alpha